Tag: CAPTIS

Filterlex Medical Announces Positive Results from A First-In-Human Study for the CAPTIS® Full-Body Embolic Protection Device

Coronary/Structural Heart by 0 comments

Cardiovascular data presented at EuroPCR 2022 demonstrates successful device performance during a TAVR procedure with no complications.  CAESAREA, Israel, May 31, 2022 /PRNewswire/ — Filterlex Medical Ltd., a cardiovascular medical device startup, announced today results from a first-in-human (FIH) study demonstrating the […]

Continue Reading →

Filterlex Medical Successfully Completes First-In-Human Study for CAPTIS® Full-Body Embolic Protection Device

Coronary/Structural Heart by 0 comments

Cardiovascular study results to be presented by Prof. Ran Kornowski, Director of the Cardiology Center, Rabin Medical Center at the EuroPCR 2022 conference in May CAESAREA, Israel, May 10, 2022 /PRNewswire/ — Filterlex Medical Ltd., a cardiovascular medical device startup, announced today that […]

Continue Reading →

Filterlex Medical Closes a $6Million Series A1 Investment to Accelerate the CAPTIS® Cardiovascular Clinical Program

Financial by 0 comments

CAESAREA, Israel, Nov. 18, 2021 /PRNewswire/ — Filterlex Medical, a cardiovascular medical device startup, announced today that it has recently completed a US $6 Million series A1 investment round from leading private healthcare investors. The financing will accelerate implementation of the company’s CAPTIS® clinical program. The […]

Continue Reading →